Current Edition


OGT expands direct sales and support infrastructure in Europe

Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced that it is now directly selling Cytocell Fluorescence In Situ Hybridisation (FISH) products through several …

Continue Reading →

Pfizer Expands Investment in Biotech through Pfizer Ventures

Company will spend $600 million on emerging/growth enterprises, with a focus on neuroscience. Pfizer Ventures, the venture capital arm of Pfizer, Inc, was founded in …

Continue Reading →